Compositions and Methods for Treating Social Anxiety

A method of treating social anxiety in a patient comprising the steps of:

• a) administering a therapeutic amount of a β-adrenergic receptor antagonist;
• b) administering, either before, after, or simultaneous to the administration of the β-adrenergic receptor antagonist, a therapeutic amount of an anti-diarrheal compound;
• and
• c) optionally administering, either before, after, or simultaneous to the administration of the β-adrenergic receptor antagonist, a therapeutic amount of an anticholinergic compound
• to a patient in need of such treatment.

A method of preventing social anxiety in a patient comprising the steps of:

• a) administering a therapeutic amount of a β-adrenergic receptor antagonist;
• b) administering, either before, after, or simultaneous to the administration of the β-adrenergic receptor antagonist, a therapeutic amount of an anti-diarrheal compound;
• and
• c) optionally administering, either before, after, or simultaneous to the administration of the β-adrenergic receptor antagonist, a therapeutic amount of an anticholinergic compound
• to a patient in need of such treatment.

A method of treating performance anxiety in a patient comprising the steps of:

• a) administering a therapeutic amount of a β-adrenergic receptor antagonist;
• b) administering, either before, after, or simultaneous to the administration of the β-adrenergic receptor antagonist, a therapeutic amount of an anti-diarrheal compound;
• and
• c) optionally administering, either before, after, or simultaneous to the administration of the β-adrenergic receptor antagonist, a therapeutic amount of an anticholinergic compound
• to a patient in need of such treatment.

A method of preventing performance anxiety in a patient comprising the steps of:

• a) administering a therapeutic amount of a β-adrenergic receptor antagonist;
• b) administering, either before, after, or simultaneous to the administration of the β-adrenergic receptor antagonist, a therapeutic amount of an anti-diarrheal compound;
• and
• c) optionally administering, either before, after, or simultaneous to the administration of the β-adrenergic receptor antagonist, a therapeutic amount of an anticholinergic compound
• to a patient in need of such treatment.

A method of treating social phobia in a patient comprising the steps of:

• a) administering a therapeutic amount of a β-adrenergic receptor antagonist;
• b) administering, either before, after, or simultaneous to the administration of the β-adrenergic receptor antagonist, a therapeutic amount of an anti-diarrheal compound;
• and
• c) optionally administering, either before, after, or simultaneous to the administration of the β-adrenergic receptor antagonist, a therapeutic amount of an anticholinergic compound
• to a patient in need of such treatment.

A method of preventing social phobia in a patient comprising the steps of:

• a) administering a therapeutic amount of a β-adrenergic receptor antagonist;
• b) administering, either before, after, or simultaneous to the administration of the β-adrenergic receptor antagonist, a therapeutic amount of an anti-diarrheal compound;
• and
• c) optionally administering, either before, after, or simultaneous to the administration of the β-adrenergic receptor antagonist, a therapeutic amount of an anticholinergic compound
• to a patient in need of such treatment.